StockData
ANI Pharmaceuticals Inc logo

ANI Pharmaceuticals Inc (ANIP) stock

ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)

Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –

ANI Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ANI Pharmaceuticals's price to sales ratio was 1.6× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 1.6× to 2.7×, with a median of 2.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×−0.4
2025Dec 31, 20251.9×+0.0
2024Dec 31, 20241.9×−0.2
2023Dec 29, 20232.1×−0.1
2022Dec 30, 20222.2×−0.4
2021Dec 31, 20212.6×+0.9
2020Dec 31, 20201.7×−1.7
2019Dec 31, 20193.4×+0.7
2018Dec 31, 20182.7×−1.7
2017Dec 29, 20174.5×−2.0
2016Dec 30, 20166.5×−0.1
2015Dec 31, 20156.6×−0.9
2013Jan 31, 20137.5×+0.9
2012Dec 31, 20126.7×−464.8
2011Jul 29, 2011471.5×+205.9
2010Dec 31, 2010265.6×–

More ANI Pharmaceuticals figures

See a number that looks wrong?